Idramantone

{{Short description|Immunostimulant}}

{{cs1 config|name-list-style=vanc|display-authors=6}}

{{Infobox drug

| drug_name =

| image = Idramantone.svg

| width = 175px

| caption =

| pronounce =

| tradename =

| Drugs.com =

| MedlinePlus =

| licence_CA =

| licence_EU =

| DailyMedID =

| licence_US =

| pregnancy_AU =

| pregnancy_category =

| dependency_liability =

| addiction_liability =

| routes_of_administration =

| class =

| ATC_prefix =

| ATC_suffix =

| legal_status =

| bioavailability =

| protein_bound =

| metabolism =

| metabolites =

| onset =

| elimination_half-life =

| duration_of_action =

| excretion =

| CAS_number = 20098-14-0

| CAS_supplemental =

| PubChem = 64184

| IUPHAR_ligand =

| DrugBank =

| ChemSpiderID = 57758

| UNII = 7J4759Y5J1

| KEGG =

| ChEBI = 48581

| ChEMBL = 2105062

| NIAID_ChemDB =

| PDB_ligand =

| synonyms = Kemantane; Kemantan; 5-Hydroxyadamantanone; 4-Oxo-1-adamantanol; 4-Oxoadamantan-1-ol; 1-Hydroxy-4-ketoadamantane

| IUPAC_name = 5-hydroxyadamantan-2-one

| C=10 | H=14 | O=2

| SMILES = C1C2CC3CC(C2)(CC1C3=O)O

| StdInChI = 1S/C10H14O2/c11-9-7-1-6-2-8(9)5-10(12,3-6)4-7/h6-8,12H,1-5H2

| StdInChIKey = TZBDEVBNMSLVKT-UHFFFAOYSA-N

}}

Idramantone, also known as kemantane or as 5-hydroxyadamantan-2-one, is an experimental immunostimulant of the adamantane group that was never marketed.{{cite book | vauthors = Buckingham J, Macdonald F | title=Dictionary of Organic Compounds | edition = Sixth, Supplement 1 | publisher=Taylor & Francis | year=1996 | isbn=978-0-412-54110-0 | url=https://books.google.com/books?id=kfhQgpqxiVgC&pg=PA152 | access-date=13 September 2024 | page=152}}{{cite book | vauthors = Morton IK, Hall JM | title=Concise Dictionary of Pharmacological Agents: Properties and Synonyms | publisher=Springer Netherlands | year=2012 | isbn=978-94-011-4439-1 | url=https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA145 | access-date=13 September 2024 | page=145}} It is described as a lymphocyte and antibody stimulant in mice and as a T-cell suppressor. The drug was first described by 1968.